In essence, our study pioneers the illumination of TRIM29-driven PERK signaling pathways in viral myocarditis pathogenesis, underscoring the therapeutic potential of targeting the TRIM29-PERK axis to combat the disease. This evidence concerns the gene EIF2AK3 and viral myocarditis.